Evidence map›Paper›PMID 23800415›Full record

ArticleMolecular oncology2013

Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.

Manisha Juneja, Katharina Ilm, Peter M Schlag, Ulrike Stein

Open access · bronzeAbstract read
In one paragraph

Article in Molecular oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 47 citations in OpenAlex.

  1. SDC1 is a critical transmembrane proteoglycan in breast cancer.World journal of surgical oncology · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Identification of Single Nucleotide Polymorphisms in PorcineAnimals : an open access journal from MDPI · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. A Network Pharmacology Approach to Uncover the Potential Mechanism of Yinchensini Decoction.Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Manisha JunejaMax-Delbrück-Center for Molecular Medicine, Robert-Rössle Str. 10, 13125 Berlin, Germany.
Katharina Ilm
Peter M Schlag
Ulrike Stein
Max Delbrück Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MACC1, Metastasis associated in colon cancer 1, is a newly identified prognostic biomarker for colorectal cancer metastasis and patient survival, when determined in the primary tumor or patient blood. MACC1 induces cell motility and proliferation in cell culture and metastasis in mouse models. MACC1 acts as a transcriptional regulator of the receptor tyrosine kinase gene Met via binding to its promoter. However, no information about the promoter of the MACC1 gene and its transcriptional regulation has been reported so far. Here we report the identification of the MACC1 promoter using a promoter luciferase construct that directs transcription of MACC1. To gain insights into the essential domains within this promoter region, we constructed 5' truncated deletion constructs. Our results show that the region from -426 to -18 constitutes the core promoter and harbors functional motifs for the binding of AP-1, Sp1, and C/EBP transcription factors as validated by site directed mutagenesis study. Using electrophoretic mobility shift assay and chromatin immunoprecipitation assay, we demonstrated the physical interaction of these transcription factors to a minimal essential MACC1 core promoter sequence. Knock down of these transcription factors using RNAi strategy reduced MACC1 expression (P < 0.001), and resulted in decrease of cell migration (P < 0.01) which could be specifically rescued by ectopic overexpression of MACC1. In human colorectal tumors, expression levels of c-Jun and Sp1 correlated significantly to MACC1 (P = 0.0007 and P = 0.02, respectively). Importantly, levels of c-Jun and Sp1 also showed significant correlation to development of metachronous metastases (P = 0.01 and P = 0.001, respectively). This is the first study identifying the MACC1 promoter and its transcriptional regulation by AP-1 and Sp1. Knowledge of the transcriptional regulation of the MACC1 gene will implicate in enhanced understanding of its role in cancer progression and metastasis.

Indexed as

Blotting, WesternCell Line, TumorCell MovementChromatin ImmunoprecipitationColorectal NeoplasmsGene Expression Regulation, NeoplasticHumansPromoter Regions, GeneticProto-Oncogene Proteins c-junSp1 Transcription FactorTrans-ActivatorsTranscription Factor AP-1Transcription FactorsMACC1 protein, humanProto-Oncogene Proteins c-junSp1 Transcription FactorTrans-ActivatorsTranscription Factor AP-1Transcription FactorsActivator protein 1AP-1CCAAT enhancer binding proteinC/EBPChIPChromatin immune precipitationColorectal cancerElectrophoretic mobility shift assayEMSAGene promoterMACC1MetastasisMetastasis associated in colon cancer 1mutMutantSp1Specificity protein 1Transcriptional regulationTranscription start siteTSSWild typewt

Identifiers

PMID23800415
PMCPMC5528453
OpenAlexW2110960566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.